Literature DB >> 23197746

Long-Term treatment of a patient with severe restless legs syndrome using intrathecal morphine.

Magdolna Hornyak1, Holger Kaube.   

Abstract

Restless legs syndrome (RLS) is a common sensorimotor disorder.(1) The symptoms have a strong circadian rhythmicity and are most severe at night and at rest. In the most severe cases, symptoms are accompanied by serious sleep disturbances and unbearable paresthesias. First-line treatments of RLS are dopamine agonists, but GABAergic anticonvulsants and opioids are also effective.(2,3) Patients with the most severe RLS are often treated with oral opioids.(4) The use of these may, however, be limited due to side effects. The intrathecal administration of opioids results in better pain relief and fewer side effects in severe chronic pain. Case reports of 4 patients have documented excellent results with short-term use of intrathecal opioids also in RLS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23197746     DOI: 10.1212/WNL.0b013e318278b5e7

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  3 in total

1.  Treatment Options in Intractable Restless Legs Syndrome/Willis-Ekbom Disease (RLS/WED).

Authors:  Fabrizio Rinaldi; Andrea Galbiati; Sara Marelli; Luigi Ferini Strambi; Marco Zucconi
Journal:  Curr Treat Options Neurol       Date:  2016-02       Impact factor: 3.598

Review 2.  Restless legs syndrome-current therapies and management of augmentation.

Authors:  Claudia Trenkwalder; Juliane Winkelmann; Yuichi Inoue; Walter Paulus
Journal:  Nat Rev Neurol       Date:  2015-07-28       Impact factor: 42.937

Review 3.  Intractable restless legs syndrome: role of prolonged-release oxycodone-naloxone.

Authors:  Stefano de Biase; Mariarosaria Valente; Gian Luigi Gigli
Journal:  Neuropsychiatr Dis Treat       Date:  2016-02-23       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.